Factors | Univariate | Multivariate | |||
---|---|---|---|---|---|
P value | HR | 95%CI | P value | ||
Gender(M/F) | 0.946 | Â | Â | Â | |
Age(≤60/>60y) | 0.317 |  |  |  | |
Tumor type (naïve/recurrent) | 0.535 |  |  |  | |
Surgery history of liver (Y/N) | 0.341 | Â | Â | Â | |
Etiology (Hepatitis/others) | 0.915 | Â | Â | Â | |
Liver cirrhosis (Y/N) | 0.927 | Â | Â | Â | |
Antiviral treatment (Y/N) | 0.143 | Â | Â | Â | |
ECOG performance status (0/1) | 0.823 | Â | Â | Â | |
Child-Pugh (A/B) | 0.490 | Â | Â | Â | |
BCLC stage of primary HCC (A/B) | 0.654 | Â | Â | Â | |
AFP (> 400/≤400 μg/L) | 0.601 |  |  |  | |
PLT (≥100/< 100 × 109/L) | 0.267 |  |  |  | |
PT (≤14/> 14 s) | 0.486 |  |  |  | |
ALB (≤35/> 35 g/L) | 0.195 |  |  |  | |
ALT (≤40/> 40 IU/L) | 0.969 |  |  |  | |
TB (≤17.1/> 17.1 mol/L) | 0.591 |  |  |  | |
Tumor number (single/multiple) | 0.008 | 2.245 | 1.168–4.317 | 0.015 | |
Location (Paracaval portion/ Caudate process/ Spiegel’s lobe) | 0.954 |  |  |  | |
Tumor size (≤2 cm /> 2 cm) | 0.878 |  |  |  | |
Puncture approach (LA/ RA/ combination approach) | 0.571 | Â | Â | Â | |
Treatment strategy | RFA/ EA/ RFA-EA | 0.546 | Â | Â | Â |
EA/RFA or RFA-EA | 0.787 | Â | Â | Â | |
RFA or EA/RFA-EA | 0.768 | Â | Â | Â | |
AM (≥ 5 mm / < 5 mm) | 0.223 |  |  |  |